Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

1.0K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.0K
CRISPR01:59

CRISPR

55.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.0K
CRISPR and crRNAs02:53

CRISPR and crRNAs

18.2K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

Nature genetics·2026
Same author

Unknown Duration or Late Syphilis Cases with High Titers - North Carolina, 2015 & 2023.

Sexually transmitted diseases·2026
Same author

Doxycycline post-exposure prophylaxis may dramatically reduce syphilis among gay, bisexual, and other men who have sex with men: a modeling study.

Sexually transmitted diseases·2026
Same author

CDK10 loss primes tumor cells for transcriptional vulnerability and sensitizes to CDK12/13 inhibition.

Cell death & disease·2026
Same author

Timeliness of Treatment Initiation among U.S. Syphilis Cases in 2023.

Sexually transmitted diseases·2026
Same author

Multiplexed TrAEL-seq captures DNA replication dynamics in mammalian cells.

Nucleic acids research·2026

Related Experiment Video

Updated: Nov 20, 2025

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

22.7K

Minimal genome-wide human CRISPR-Cas9 library.

Emanuel Gonçalves1, Mark Thomas1, Fiona M Behan1

  • 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Genome Biology
|January 22, 2021
PubMed
Summary

We developed MinLibCas9, a smaller CRISPR-Cas9 library that maintains high efficiency for gene editing screens. This optimized library reduces reagent size, enabling broader applications in complex biological models.

Keywords:
CRISPR-Cas9Genome-wideKS scoreMinimal libraryOrganoid

More Related Videos

A Universal Protocol for Large-scale gRNA Library Production from any DNA Source
10:32

A Universal Protocol for Large-scale gRNA Library Production from any DNA Source

Published on: December 6, 2017

11.4K
HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

8.5K

Related Experiment Videos

Last Updated: Nov 20, 2025

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

22.7K
A Universal Protocol for Large-scale gRNA Library Production from any DNA Source
10:32

A Universal Protocol for Large-scale gRNA Library Production from any DNA Source

Published on: December 6, 2017

11.4K
HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

8.5K

Area of Science:

  • Molecular Biology
  • Genomics
  • Biotechnology

Background:

  • CRISPR-Cas9 gene editing relies on guide RNA libraries, which are often large and cumbersome.
  • Existing CRISPR-Cas9 libraries face limitations in size, hindering their application in various research settings.

Purpose of the Study:

  • To design a minimized genome-wide human CRISPR-Cas9 library (MinLibCas9) with reduced size and preserved functionality.
  • To enhance the efficiency and applicability of CRISPR-Cas9 screening technologies.

Main Methods:

  • Mining large-scale gene loss-of-function datasets to identify essential guide RNAs.
  • Optimizing the design of a human CRISPR-Cas9 library for genome-wide screening.

Main Results:

  • Achieved a >42% reduction in library size compared to existing CRISPR-Cas9 libraries.
  • Preserved assay sensitivity and specificity with the minimized library.
  • Demonstrated backward compatibility with existing CRISPR-Cas9 datasets.

Conclusions:

  • MinLibCas9 offers a significantly smaller yet effective reagent for CRISPR-Cas9 screens.
  • The optimized library expands the dynamic range and applicability of CRISPR screens in complex models.
  • MinLibCas9 facilitates broader adoption of CRISPR-Cas9 technology in diverse research areas.